Braasch Biotech LLC
www.braaschbiotech.comPrivately owned biopharmaceutical company pioneering the use of anti-somatostatin vaccine use. Our products (under the trademark Somatovac) have been used for treatment of metaboloic conditions, such as obesity, and productivity enhancement (livestock). Braasch has a US and international patent portfolio for our core technology (protein), application as vaccines, adjuvants and metabolic adjustment.
Read more
Privately owned biopharmaceutical company pioneering the use of anti-somatostatin vaccine use. Our products (under the trademark Somatovac) have been used for treatment of metaboloic conditions, such as obesity, and productivity enhancement (livestock). Braasch has a US and international patent portfolio for our core technology (protein), application as vaccines, adjuvants and metabolic adjustment.
Read more
Country
State
South Dakota
Industry
Employees
1-10
Founded
2008
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
President and Chief Security Officer
Email ****** @****.comPhone (***) ****-****Member Board of Directors
Email ****** @****.comPhone (***) ****-****
Technologies
(5)
We'll help you understand if Lusha can solve your business needs.
